Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Advanced Cancer|Breast Cancer|Sarcoma|Pancreatic Cancer|Small Cell Lung Cancer|Ovarian
Interventions: DRUG: Pembrolizumab|DRUG: Gemcitabine|DRUG: Docetaxel|DRUG: Nab-paclitaxel|DRUG: Vinorelbine|DRUG: Irinotecan|DRUG: Liposomal Doxorubicin
Sponsor: Western Regional Medical Center